Friends or Foes? Emerging Impacts of Biological Toxins

Jenner, 2017 Black, 1999, Claude Bernard on the action of curare, BMJ, 319, 622, 10.1136/bmj.319.7210.622 Dale, 1934, Chemical transmission of the effects of nerve impulses, BMJ, 1, 835, 10.1136/bmj.1.3827.835 Dutertre, 2017, Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms, Neuropharmacology, 127, 196, 10.1016/j.neuropharm.2017.06.011 Diochot, 2012, Black mamba venom peptides target acid-sensing ion channels to abolish pain, Nature, 490, 552, 10.1038/nature11494 Osteen, 2016, Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain, Nature, 534, 494, 10.1038/nature17976 Moczydlowski, 2016, On the natural and unnatural history of the voltage-gated Na+ channel, Curr. Top. Membr., 78, 3, 10.1016/bs.ctm.2016.06.002 Harvey, 2014, Toxins and drug discovery, Toxicon, 92, 193, 10.1016/j.toxicon.2014.10.020 Robinson, 2017, Venom peptides as therapeutics, advances, challenges and the future of venom-peptide discovery, Expert Rev. Proteomics., 14, 931, 10.1080/14789450.2017.1377613 Cushman, 1991, History of the design of captopril and related inhibitors of angiotensin converting enzyme, Hypertension, 17, 589, 10.1161/01.HYP.17.4.589 Cushman, 1977, Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids, Biochemistry, 16, 5484, 10.1021/bi00644a014 Scarborough, 1993, Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa, J. Biol. Chem., 268, 1066, 10.1016/S0021-9258(18)54042-4 Hartman, 1992, Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors, J. Med. Chem., 35, 4640, 10.1021/jm00102a020 Hillyard, 1992, A new Conus peptide ligand for mammalian presynaptic Ca2+ channels, Neuron, 9, 69, 10.1016/0896-6273(92)90221-X Göke, 1993, Exendin-4 is a high potency agonist and truncated exendin- (9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells, J. Biol. Chem., 268, 19650, 10.1016/S0021-9258(19)36565-2 Pennington, 2018, Peptide therapeutics from venom: current status and potential, Bioorg. Med. Chem., 26, 2738, 10.1016/j.bmc.2017.09.029 Pellett, 2012, Learning from the past: historical aspects of bacterial toxins as pharmaceuticals, Curr. Opin. Microbiol., 15, 292, 10.1016/j.mib.2012.05.005 Frampton, 2018, OnabotulinumtoxinA: a review in the prevention of chronic migraine, Drugs, 78, 589, 10.1007/s40265-018-0894-6 Gill, 1982, Bacterial toxins: a table of lethal amounts, Microbiol. Rev., 46, 86, 10.1128/MMBR.46.1.86-94.1982 Arnon, 2001, Botulinum toxin as a biological weapon: medical and public health management, JAMA, 285, 1059, 10.1001/jama.285.8.1059 Pirazzini, 2017, Botulinum neurotoxins: biology, pharmacology, and toxicology, Pharmacol. Rev., 69, 200, 10.1124/pr.116.012658 Casewell, 2014, Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms, Proc. Natl. Acad. Sci. U. S. A., 111, 9205, 10.1073/pnas.1405484111 Dutertre, 2014, Evolution of separate predation- and defence-evoked venoms in carnivorous cone snails, Nat. Commun., 5, 10.1038/ncomms4521 Gao, 2017, A big store of conotoxins for novel drug discovery, Toxins, 9, 397, 10.3390/toxins9120397 Vonk, 2013, The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system, Proc. Natl. Acad. Sci. U. S. A., 110, 20651, 10.1073/pnas.1314702110 Cheng, 2016, Recent development of mass spectrometry and proteomics applications in identification and typing of bacteria, Proteomics Clin. Appl., 10, 346, 10.1002/prca.201500086 Mladic, 2017, Rapid screening and identification of ACE inhibitors in snake venoms using at-line nanofractionation LC-MS, Anal. Bioanal. Chem., 409, 5987, 10.1007/s00216-017-0531-3 Slagboom, 2018, Neurotoxicity fingerprinting of venoms using on-line microfluidic AChBP profiling, Toxicon, 148, 213, 10.1016/j.toxicon.2018.04.022 Cao, 2013, TRPV1 structures in distinct conformations reveal activation mechanisms, Nature, 504, 113, 10.1038/nature12823 Shen, 2018, Structural basis for the modulation of voltage-gated sodium channels by animal toxins, Science, 362, 10.1126/science.aau2596 Anand, 2014, Sample limited characterization of a novel disulphide-rich venom peptide toxin from terebrid marine snail Terebra variegata, PLoS One, 9, 10.1371/journal.pone.0094122 Walker, 2018, The assassin bug Pristhesancus plagipennis produces two distinct venoms in separate gland lumens, Nat. Commun., 9, 10.1038/s41467-018-03091-5 Vilarino, 2018, Human poisoning from marine toxins: unknowns for optimal consumer protection, Toxins, 10, 324, 10.3390/toxins10080324 Akcan, 2013, Synthesis of cyclic disulfide-rich peptides, Methods Mol. Biol., 1047, 89, 10.1007/978-1-62703-544-6_6 Wang, 2018, Designing macrocyclic disulfide-rich peptides for biotechnological applications, Nat. Chem. Biol., 14, 417, 10.1038/s41589-018-0039-y Saez, 2017, A strategy for production of correctly folded disulfide-rich peptides in the periplasm of E. coli, Vol. 1586 Assunção, 2017, Biotechnological and pharmacological applications of biotoxins and other bioactive molecules from dinoflagellates, Mar. Drugs, 15, 393, 10.3390/md15120393 Ruiming, 2015, Designer and natural peptide toxin blockers of the KcsA potassium channel identified by phage display, Proc. Natl. Acad. Sci. U. S. A., 112, E7013, 10.1073/pnas.1514728112 Prentis, 2018, Sea anemones: quiet achievers in the field of peptide toxins, Toxins, 10, 36, 10.3390/toxins10010036 Sadeghi, 2018, Structure-activity studies reveal the molecular basis for GABAB-receptor mediated inhibition of high voltage-activated calcium channels by α-conotoxin Vc1. 1, ACS Chem. Biol., 13, 1577, 10.1021/acschembio.8b00190 Butte, 2014, Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors, Neurosurg. Focus, 36, E1, 10.3171/2013.11.FOCUS13497 Duggan, 2015, Bioactive mimetics of conotoxins and other venom peptides, Toxins, 7, 4175, 10.3390/toxins7104175 Fasoli, 2014, Mechanistic insight into CM18-Tat11 peptide membrane-perturbing action by whole-cell patch-clamp recording, Molecules, 19, 9228, 10.3390/molecules19079228 Rispoli, 2017, Studying the mechanism of membrane permeabilisation induced by antimicrobial peptides using patch clamp techniques, 1548, 10.1007/978-1-4939-6737-7_18 Sekizawa, 1997, Molecular cloning of cDNA for lysenin, a novel protein in the earthworm Eisenia foetida that causes contraction of vascular smooth muscle, Gene, 191, 97, 10.1016/S0378-1119(97)00047-4 Herec, 2008, Secondary structure and orientation of the pore-forming toxin lysenin in a sphingomyelin-containing membrane, Biochem. Biophys. Acta, 1778, 872, 10.1016/j.bbamem.2007.12.004 Bokori-Brown, 2016, Cryo-EM structure of lysenin pore elucidates membrane insertion by an aerolysin family protein, Nat. Commun., 7, 11293, 10.1038/ncomms11293 Heath, 2018, Visualization of diffusion limited antimicrobial peptide attack on supported lipid membranes, Soft Matter, 14, 6146, 10.1039/C8SM00707A Dumitru, 2018, High-resolution mapping and recognition of lipid domains using AFM with toxin-derivatised probes, Chem. Commun., 54, 6903, 10.1039/C8CC02201A Clarke, 2009, Continuous base identification for single-molecule nanopore DNA sequencing, Nat. Nanotechnol., 4, 265, 10.1038/nnano.2009.12 Ayub, 2016, Engineered transmembrane pores, Curr. Opin. Chem. Biol., 34, 117, 10.1016/j.cbpa.2016.08.005 Tak, 2014, Animal venoms in medicine, Vol. 1, 252 Li, 2018, Snake venoms in cancer therapy: past, present and future, Toxins (Basel), 10, E346, 10.3390/toxins10090346 Thum, 2002, Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and -4, Exp. Clin. Endocrinol. Diabetes, 110, 113, 10.1055/s-2002-29087 Furman, 2012, The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent, Toxicon, 59, 464, 10.1016/j.toxicon.2010.12.016 Castañeda, 2009, Discovery and characterization of cnidarian peptide toxins that affect neuronal potassium ion channels, Toxicon, 54, 1119, 10.1016/j.toxicon.2009.02.032 Castañeda, 1995, Characterization of a potassium channel toxin from the Caribbean sea anemone Stichodactyla helianthus, Toxicon, 33, 603, 10.1016/0041-0101(95)00013-C Pennington, 2015, Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK, Mar. Drugs, 13, 529, 10.3390/md13010529 Tarcha, 2017, Safety and pharmacodynamics of Dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: a randomized phase 1b trial, PLoS One, 12, 10.1371/journal.pone.0180762 Netirojjanakul, 2017, Progress and challenges in the optimization of toxin peptides for development as pain therapeutics, Curr. Opin. Chem. Biol., 38, 70, 10.1016/j.cbpa.2017.03.004 Murray, 2015, Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel, J. Med. Chem., 58, 2299, 10.1021/jm501765v Richards, 2018, Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death, Proc. Natl. Acad. Sci. U. S. A., 115, E8077, 10.1073/pnas.1804764115 Destoumieux-Garzón, 2018, The One Health concept: 10 years old and a long road ahead, Front. Vet. Sci., 5, 14, 10.3389/fvets.2018.00014 Ferri, 2017, Antimicrobial resistance: a global emerging threat to public health systems, Crit. Rev. Food Sci. Nutr., 57, 2857, 10.1080/10408398.2015.1077192 Laxminarayan, 2013, Antibiotic resistance: the need for global solutions, Lancet Infect. Dis., 13, 1057, 10.1016/S1473-3099(13)70318-9 Primon-Barrosa, 2017, Animal venom peptides: potential for new antimicrobial agents, Curr. Top. Med. Chem., 17, 1116 Liu, 2018, Therapeutic potential of a scorpion venom-derived antimicrobial peptide and its homologs against antibiotic-resistant gram-positive bacteria, Front. Microbiol., 29, 1159, 10.3389/fmicb.2018.01159 Morris, 2012, Pegylation of antimicrobial peptides maintains the active peptide confirmation, model membrane interactions and antimicrobial activity while improving lung biocompatibility following airway delivery, Antimicrob. Agents Chemother., 56, 3298, 10.1128/AAC.06335-11 Aguirre, 2016, Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials, Adv. Drug Deliv. Rev., 106, 223, 10.1016/j.addr.2016.02.004 Samy, 2016, A brief update on potential molecular mechanisms underlying antimicrobial and wound healing potency of snake venom molecules, Biochem. Pharmacol., 115, 1, 10.1016/j.bcp.2016.03.006 Royal, 2017, Therapeutic potential of cholera toxin B subunit for the treatment of inflammatory diseases of the mucosa, Toxins, 9, 379, 10.3390/toxins9120379 Lycke, 2018, ADP-ribosylating enterotoxins as vaccine adjuvants, Curr. Opin. Pharmacol., 41, 42, 10.1016/j.coph.2018.03.015 Labovitiadi, O. et al. Janssen Pharmaceuticals. ExPEC glycoconjugate vaccine formulations. WO2018077853A1 Hardy, 2013, Isolation of an orally active insecticidal toxin from the venom of an Australian tarantula, PLoS One, 8, 10.1371/journal.pone.0073136 Jennings, 2016, Aquatic food security: insights into challenges and solutions from an analysis of interactions between fisheries, aquaculture, food safety, human health, fish and human welfare, economy and environment, Fish Fish., 17, 893, 10.1111/faf.12152 Hallegraef, 2015, Harmful marine algal blooms and climate change: progress on a formidable predictive challenge, 181 Percival, 2014, Legionella, 155 Botana, 2016, A toxicological perspective to climate change: aquatic toxins, Chem. Res. Toxicol., 29, 619, 10.1021/acs.chemrestox.6b00020 Jacobs, 2015, A framework for examining climate-driven changes to the seasonality and geographical range of coastal pathogens and harmful algae, Clim. Risk Manage., 8, 16, 10.1016/j.crm.2015.03.002 Turner, 2015, Detection of the pufferfish toxin tetrodotoxin in European bivalves, England, 2013 to 2014, Eurosurveillance, 20, 2, 10.2807/1560-7917.ES2015.20.2.21009 Baker-Austin, 2013, Impacts of climate change on human health, MCCIP Sci. Rev., 2013, 257 Gehringer, 2014, Climate change and regulation of hepatotoxin production in cyanobacteria, FEMS Microbiol. Ecol., 88, 1, 10.1111/1574-6941.12291 Wells, 2015, Harmful algal blooms and climate change: learning from the past and present to forecast the future, Harmful Algae, 49, 68, 10.1016/j.hal.2015.07.009 Miraglia, 2009, Climate change and food safety: an emerging issue with special focus on Europe, Food Chem. Toxicol., 47, 1009, 10.1016/j.fct.2009.02.005 Paerl, 2012, Climate change: links to global expansion of harmful cyanobacteria, Water Res., 46, 1349, 10.1016/j.watres.2011.08.002 Lürling, 2017, Eutrophication and warming boost cyanobacterial biomass and microcystins, Toxins, 9, E64, 10.3390/toxins9020064 Carey, 2012, Occurrence and toxicity of the cyanobacterium Gloeotrichia echinulata in low-nutrient lakes in the north eastern United States, Aquat. Ecol., 46, 395, 10.1007/s10452-012-9409-9 Przytulska, 2017, Increased risk of cyanobacterial blooms in northern high-latitude lakes through climate warming and phosphorus enrichment, Freshw. Biol., 62, 1986, 10.1111/fwb.13043 Battilani, 2012 Medina, 2017, Climate change, food security and mycotoxins: do we know enough?, Fungal Biol. Rev., 31, 143, 10.1016/j.fbr.2017.04.002 Van der Fels-Klerx, 2016, Modelling climate change impacts on mycotoxin contamination, World Mycotoxin J., 9, 717, 10.3920/WMJ2016.2066